Cg Oncology Inc [CGON] stock is trading at $33.69, up 1.87%. An important factor to consider is whether the stock is rising or falling in short-term value. The CGON shares have gain 25.62% over the last week, with a monthly amount glided 38.36%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cg Oncology Inc [NASDAQ: CGON] stock has seen the most recent analyst activity on August 19, 2025, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $55. On May 02, 2025, JP Morgan initiated with a Overweight rating and assigned a price target of $41 on the stock. Scotiabank started tracking the stock assigning a Sector Perform rating and suggested a price target of $23 on April 16, 2025. TD Cowen initiated its recommendation with a Buy. UBS started tracking with a Buy rating for this stock on October 24, 2024, and assigned it a price target of $60. In a note dated September 23, 2024, RBC Capital Mkts initiated an Outperform rating and provided a target price of $66 on this stock.
Cg Oncology Inc [CGON] stock has fluctuated between $14.80 and $40.47 over the past year. Currently, Wall Street analysts expect the stock to reach $55 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $33.69 at the most recent close of the market. An investor can expect a potential return of 63.25% based on the average CGON price forecast.
Analyzing the CGON fundamentals
Cg Oncology Inc [NASDAQ:CGON] reported sales of 0.55M for the trailing twelve months, which represents a drop of -100.00%. Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at -285.46%, Pretax Profit Margin comes in at -232.45%, and Net Profit Margin reading is -157.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.13 and Total Capital is -0.23. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 32.55 points at the first support level, and at 31.41 for the second support level. However, for the 1st resistance point, the stock is sitting at 34.78, and for the 2nd resistance point, it is at 35.87.
Ratios To Look Out For
For context, Cg Oncology Inc’s Current Ratio is 22.15. On the other hand, the Quick Ratio is 22.15, and the Cash Ratio is 0.48. Considering the valuation of this stock, the price to sales ratio is 4670.52, the price to book ratio is 3.83.
Transactions by insiders
Recent insider trading involved Mulay James, Director, that happened on Sep 05 ’25 when 27015.0 shares were sold. Director, JAMES MULAY completed a deal on Sep 05 ’25 to buy 27015.0 shares. Meanwhile, Director Song Hong Fang sold 100000.0 shares on Sep 03 ’25.
